Skip to main content
. 2021 May;147(5):1830–1837.e15. doi: 10.1016/j.jaci.2020.10.004

Table IV.

Effect size of the association of HLA-DRB1∗10:01 with immediate hypersensitivity reactions broken down by drug classes and individual drugs

Drug Ethnicity No. of cases Case MAF OR (95% CI) P value
Cephalosporins Caucasian 162 0.019 2.03 (0.82-5.07) .13
 Cefaclor Caucasian 23 0
 Cefazolin Caucasian 17 0.059 6.12 (1.32-28.30) .02
 Cefotaxime Italian 17 0
 Ceftazidime Italian 17 0
 Ceftriaxone Italian 48 0.010 1.05 (0.13-8.33) .96
 Cefuroxime Caucasian 14 0.050 2.90 (0.37-22.76) .31
Penicillins Caucasian 501 0.036 3.07 (2.04-4.62) 7.42 × 10−8
 Amoxicillin Caucasian 166 0.042 3.48 (1.92-6,28) 3.74 × 10−5
 Ampicillin Italian 29 0.014 1.98 (0.25-15.79) .52
 Co-amoxiclav Caucasian 218 0.034 2.85 (1.60-5.10) .0004
 Phenoxymethylpenicillin Caucasian 25 0.080 6.66 (2.14-20.79) .001
 Piperacillin Caucasian 18 0.028 2.32 (0.29-18.78) .43
 Bacampicillin Italian 21 0.024 2.09 (0.26-17.03) .49

MAF, Minor allele frequency. OR and P value as defined in Table II.

Ethnicity—Caucasian is applied to patients of Spanish, Italian, and Northern European descent and confirmed by principal component analysis. Where only 1 nationality was available for a particular drug, this is indicated and only appropriate matching controls were chosen.